Procept (PRCT): 50% rise on high volume. Why? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?

PRCT 31.32

+1.3%

Nov 11 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: T. Mann who wrote (123)	4/18/1997 11:47:00 AM
From: Gerald Thomas	of 455

The only quibble I would have is that they did do animal studdies on rabbits and that is a fact ... As to the other stuff the cash crunch is not news and is in my oppinion one reason they suspended the systemic trial... I believe there is a possibility that they feel they can get financing with the topical trial and is such stated in their last 10k that they are in discussions with NIH and the British Medical organization that is listed... I think the stock price is related to limited info. put out by company combined with suspending and changing trials... The cash info has been known by the investment comunity since late last year......

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next